BG102873A - Indole derivatives useful as endothelium receptor antagonists - Google Patents

Indole derivatives useful as endothelium receptor antagonists

Info

Publication number
BG102873A
BG102873A BG102873A BG10287398A BG102873A BG 102873 A BG102873 A BG 102873A BG 102873 A BG102873 A BG 102873A BG 10287398 A BG10287398 A BG 10287398A BG 102873 A BG102873 A BG 102873A
Authority
BG
Bulgaria
Prior art keywords
alkyl
conh
individually
optionally
mean
Prior art date
Application number
BG102873A
Other languages
Bulgarian (bg)
English (en)
Inventor
David RAWSON
Kevin DACK
Roger DICKINSON
Kim James
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG102873A publication Critical patent/BG102873A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG102873A 1996-05-09 1998-10-27 Indole derivatives useful as endothelium receptor antagonists BG102873A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9609641.7A GB9609641D0 (en) 1996-05-09 1996-05-09 Compounds useful in therapy
PCT/EP1997/001882 WO1997043260A1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
BG102873A true BG102873A (en) 1999-11-30

Family

ID=10793387

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102873A BG102873A (en) 1996-05-09 1998-10-27 Indole derivatives useful as endothelium receptor antagonists

Country Status (43)

Country Link
US (4) US6017945A (tr)
EP (1) EP0901470B1 (tr)
JP (1) JP3245179B2 (tr)
KR (1) KR100331217B1 (tr)
CN (1) CN1124262C (tr)
AP (1) AP830A (tr)
AR (1) AR007030A1 (tr)
AT (1) ATE263151T1 (tr)
AU (1) AU717849B2 (tr)
BG (1) BG102873A (tr)
BR (1) BR9709072A (tr)
CA (1) CA2253876A1 (tr)
CO (1) CO4650036A1 (tr)
CZ (1) CZ292928B6 (tr)
DE (1) DE69728392T2 (tr)
DK (1) DK0901470T3 (tr)
DZ (1) DZ2227A1 (tr)
EA (1) EA001471B1 (tr)
ES (1) ES2218675T3 (tr)
GB (1) GB9609641D0 (tr)
HK (1) HK1019149A1 (tr)
HN (1) HN1997000058A (tr)
HR (1) HRP970249B1 (tr)
HU (1) HUP9901245A3 (tr)
ID (1) ID16878A (tr)
IL (1) IL125903A0 (tr)
IS (1) IS1856B (tr)
MA (1) MA26428A1 (tr)
NO (1) NO312547B1 (tr)
NZ (1) NZ332640A (tr)
OA (1) OA10896A (tr)
PE (1) PE65098A1 (tr)
PL (1) PL329725A1 (tr)
PT (1) PT901470E (tr)
SI (1) SI0901470T1 (tr)
SK (1) SK150398A3 (tr)
TN (1) TNSN97078A1 (tr)
TR (1) TR199802269T2 (tr)
TW (1) TW491838B (tr)
UA (1) UA50767C2 (tr)
UY (1) UY24546A1 (tr)
WO (1) WO1997043260A1 (tr)
ZA (1) ZA973963B (tr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) * 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
RU2262935C2 (ru) * 1999-02-10 2005-10-27 Астразенека Аб Производные хиназолина в качестве ингибиторов ангиогенеза
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
DK1397130T3 (da) 2001-06-20 2007-11-12 Wyeth Corp Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2006510672A (ja) 2002-12-10 2006-03-30 ワイス プラスミノーゲン活性化因子の阻害因子−１（ｐａｉ−１）の阻害剤としての置換インドールオキソ−アセチルアミノ酢酸誘導体
AU2003297727A1 (en) 2002-12-10 2004-06-30 Wyeth Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
MXPA05006288A (es) 2002-12-10 2005-08-19 Wyeth Corp Derivados del acido 3-carbonil-1h-indol-1-ilacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1).
ATE411288T1 (de) 2002-12-10 2008-10-15 Wyeth Corp Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
JP2007500253A (ja) * 2003-01-22 2007-01-11 イーライ リリー アンド カンパニー ステロイドホルモン核内受容体のインドール誘導体モジュレーター
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
JP2005109006A (ja) * 2003-09-29 2005-04-21 Tdk Corp 高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
MX2007002178A (es) 2004-08-23 2007-04-02 Wyeth Corp Acidos de oxazolo-naftilo como moduladores del inhibidor del activador de plasminogeno tipo 1 (pai-1) util en el tratamiento de trombosis y enfermedades cardiovasculares.
JP2009504762A (ja) 2005-08-17 2009-02-05 ワイス 置換インドール類およびそれらの使用方法
WO2007119214A2 (en) * 2006-04-13 2007-10-25 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
CN106674065A (zh) * 2016-12-07 2017-05-17 贵州大学 一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) * 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
WO2020176599A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637355A (tr) * 1962-09-14
DE1950346B2 (de) * 1968-10-08 1973-06-28 Sumitomo Chemical Co 2-indolylessigsaeureverbindungen und diese verbindungen enthaltende arzneipraeparate
US4397079A (en) * 1981-03-30 1983-08-09 International Business Machines Corp. Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
JP3334087B2 (ja) * 1990-09-10 2002-10-15 アヴェンティス ファーマシューティカルズ インコーポレイテッド 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された二環式アリール化合物
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DE69422742T2 (de) * 1993-03-19 2000-08-17 Merck & Co., Inc. Phenoxyphenylessigsäurederivate
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
US6017945A (en) 2000-01-25
GB9609641D0 (en) 1996-07-10
NO985225D0 (no) 1998-11-09
US20010014677A1 (en) 2001-08-16
MA26428A1 (fr) 2004-12-20
HRP970249B1 (en) 2003-06-30
ZA973963B (en) 1998-11-09
AP830A (en) 2000-05-03
JPH11508285A (ja) 1999-07-21
US6384070B2 (en) 2002-05-07
KR100331217B1 (ko) 2002-05-09
TNSN97078A1 (fr) 2005-03-15
NO312547B1 (no) 2002-05-27
CO4650036A1 (es) 1998-09-03
CZ358298A3 (cs) 1999-08-11
UA50767C2 (uk) 2002-11-15
IS1856B (is) 2003-02-21
EA001471B1 (ru) 2001-04-23
DE69728392D1 (de) 2004-05-06
IL125903A0 (en) 1999-04-11
DE69728392T2 (de) 2005-01-13
CN1124262C (zh) 2003-10-15
PE65098A1 (es) 1998-10-29
HUP9901245A3 (en) 2002-01-28
BR9709072A (pt) 1999-08-03
DZ2227A1 (fr) 2002-12-25
AU2697897A (en) 1997-12-05
US6136843A (en) 2000-10-24
KR20000010879A (ko) 2000-02-25
TW491838B (en) 2002-06-21
PL329725A1 (en) 1999-04-12
HUP9901245A2 (hu) 1999-08-30
OA10896A (en) 2001-10-11
CN1216531A (zh) 1999-05-12
US6306852B1 (en) 2001-10-23
CZ292928B6 (cs) 2004-01-14
ES2218675T3 (es) 2004-11-16
WO1997043260A1 (en) 1997-11-20
DK0901470T3 (da) 2004-07-12
NO985225L (no) 1998-11-09
CA2253876A1 (en) 1997-11-20
TR199802269T2 (tr) 2001-12-21
EP0901470A1 (en) 1999-03-17
JP3245179B2 (ja) 2002-01-07
EA199800908A1 (ru) 1999-06-24
AP9700982A0 (en) 1997-07-31
EP0901470B1 (en) 2004-03-31
HN1997000058A (es) 1997-06-26
HK1019149A1 (en) 2000-01-14
ATE263151T1 (de) 2004-04-15
SI0901470T1 (en) 2004-08-31
SK150398A3 (en) 1999-03-12
AR007030A1 (es) 1999-10-13
NZ332640A (en) 2001-03-30
IS4838A (is) 1998-08-28
PT901470E (pt) 2004-07-30
HRP970249A2 (en) 1998-06-30
AU717849B2 (en) 2000-04-06
ID16878A (id) 1997-11-20
UY24546A1 (es) 2000-09-29

Similar Documents

Publication Publication Date Title
BG102873A (en) Indole derivatives useful as endothelium receptor antagonists
LTC1265862I2 (lt) 2-Okso-1-pirolidino dariniai, jų gamybos būdas ir jų panaudojimas
EA200101194A1 (ru) Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств
EA200100058A1 (ru) 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
CZ305838B6 (cs) N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
ATE103604T1 (de) Substituierte 5-((tetrazolyl)alkenyl>-imidazole.
ATE249213T1 (de) Pentafluorobenzensulfonamiden und analoge
FI905481A0 (fi) Substituerade n-(imidazolyl) -alkylalaninderivat.
ES2181995T3 (es) Derivados de bencimidazol y uso como antagonistas del factor de liberacion de la corticotropina.
MY138826A (en) 2,7-substituted indoles
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ATE188701T1 (de) Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten
ATE250586T1 (de) Imidazoline derivate,ihre herstellung und pharmazeutische zusammensetzungen die sie enthalten
MD554G2 (ro) Derivaţi noi ai triazolpirimidinelor, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice care le conţin
PT804186E (pt) Compostos alcaloides diterpenicos de indole
ATE189889T1 (de) Indol derivate als glutamat antagonisten
BR9708171A (pt) Uso de derivados de 4-fenil-3,6-di-hidro-2h-piridila como bloqueadores de subtipo de receptor nmda
EA200300850A1 (ru) Применение антагонистов рецептора gal3 при лечении депрессии и/или тревоги и соединения, полезные в таких способах
NO996128L (no) Nye pentaerytrittderivater, deres fremstilling og anvendelse så vel som mellomprodukter for deres syntese
EA200400877A1 (ru) 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи
NO20042729L (no) Heksasykliske forbindelser